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1. Introduction
In the realm of medical practice, the word “embolism” has many implications 
to many people [1, 2], with most providers instinctively placing this word within a 
negative context [3–5]. Derived from the Greek word, ἐμβολισμός, this term most 
literally means “interposition” [6]. Yet regardless of how benign the etymology 
may be, the clinical context is quite the opposite—synonymous with much dreaded 
morbidity and mortality [1, 2, 7–10]. Whether the embolus consists of a blood clot 
[8], a fat globule [11], a bubble of gas [12], amniotic fluid [9, 10], or even an iatro-
genic or traumatic foreign body [13, 14], the unfavorable connotations persist even 
if the patient has few or no associated symptoms and requires no intervention.
The primary goal of this book is to provide the reader with an overview of 
the most common types of embolic phenomena encountered in clinical practice, 
including some of the key related diagnostic and therapeutic areas. The current 
collection of chapters includes important contributions in the areas of pulmonary 
embolism (PE), fat embolism (FE), embolic complications of nonmalignant cardiac 
tumors, acute arterial embolism (AAE) of the lower extremity, thrombophilia in 
pregnancy, bullet and shrapnel embolization (BSE), and coronary artery emboliza-
tion (CAE), as well as a comprehensive chapter on venous interventions utilized in 
the management of thromboembolic disorders.
Perhaps the best way to paint the picture of the tremendous impact of “embo-
lism” globally is to present the human costs and the resources required to treat 
various types, manifestations, and complications of embolic diseases. Although 
challenging to gather, such information was compiled by our team for the purposes 
of this introductory chapter and summarized in Table 1 [12, 14–37]. Although far 
from comprehensive, we hope to provide the reader with valuable insight into the 
gravity of the collective problem.
2. Embolism types: a synopsis
No discussion of “embolism” can be complete without the discussion of risk 
factors, diagnostics including laboratory and imaging tests, and therapeutic 
considerations. Here, one must emphasize the importance of looking at the “totality 
of evidence,” considering things like clinical suspicion, presence/absence of specific 
risk factors, positive/negative predictive values, diagnostic test sensitivity/specific-
ity, and the pre−/posttest probabilities.
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Embolism type 
(alphabetical) [Reference]
Number affected Mortality Morbidity Healthcare costs Other considerations
Air emboli [12, 15–18] 0.2–1% (with central line)
0.003–0.007% (cardiac bypass)
Overall, 2.65 per 100,000 cases
14% 21.7% Neurologic complications–
encephalopathy to focal cerebral 
lesions (19–50%)
Legal: median payment $325,000/
claim
ICU admission
Amniotic fluid [19, 20] 1/22,000 pregnancies
Overall, 2–8/100,000 cases
10% of all maternal 
deaths
13–44% case 
maternal mortality
7–38% fetal 
mortality
Seizures (2.22%)
Maternal neurologic damage (4.44%)
Fetal neurologic damage (25–50%)
Shock (15%)
Coagulopathy (8.8%)
Cardiac arrest (22.2%)
Fetal NICU admission 8.8–20%
Prolonged hospitalization
Average maternal LOS–2.92 days
Average infant LOS–3.78 days
ICU admission
Massive blood transfusion
Long-term neurologic 
effects
Fat emboli [21–24] Symptomatic: 1–20% patients 
with long bone fractures (true 
incidence is likely much higher)
5–15% ARDS, pneumonia
CVA
Seizures, epilepsy (2.86%)
DIC, thrombocytopenia (37%)
Cardiac failure
ICU admission
Iatrogenic foreign body 
[14, 25–27]
Retained guidewire
Approximately 1 in 3000 cases
<2% mortality Cerebral ischemia
Infarction
Cardiac dysrhythmia, tamponade
5–32% symptomatic
Medicare: endovascular retrieval 
of foreign body—9.03 RVU which 
equates to $342.15 reimbursement
Potential legal costs if foreign body 
not immediately recognized
Requirement for 
endovascular or operative 
removal
Peripheral emboli [28–30] About 14 per 100,000 cases 17–18% death Amputation (28.9%)
Reperfusion injury (6%)
Requirement for fasciotomy, 
limb amputation, loss of 
function
Pulmonary embolism (PE) 
[31–37]
97.8 per 100,000 population/
year (hospitalization rate)
0.1–4.2% in 
hospitalized 
patients
~25% at 7 days
Up to 16% at 1 year
Bleeding related to thrombolytics 
and/or anticoagulants (4–7.5%)
Right ventricular systolic dysfunction 
(20–60%)
Between $5,500 and $11,665 
(depending on severity) with mean 
cost of $8800
$99,286/PE death (Cox)
Need for long-term 
anticoagulation
Venous stasis
Pulmonary hypertension
Recurrent PE
ARDS = Acute respiratory distress syndrome; CVA = Cerebrovascular accident; DIC = Disseminated intravascular coagulation; ICU = Intensive care unit; LOS = Length of stay; NICU = Neonatal ICU; PE = 
Pulmonary embolism; RVU = Relative value unit.
Table 1. 
Selected metrics demonstrating the global impact of embolic diseases, including considerations of both patient- and health system level considerations.
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2.1 Pulmonary embolism
Initial clinical tests obtained when a patient exhibits symptoms of a PE are com-
monly electrocardiogram (EKG), arterial blood gas (ABG) analysis, and chest X-ray 
(CXR). However, none of these studies are sufficiently sensitive or specific for 
this diagnosis. Clinical scoring systems such as the Wells or PERC score have been 
established but in isolation are not able to diagnose PE [38]; rather, they provide 
clinically relevant risk stratification. Based on such risk stratification, it is recom-
mended that a test of exclusion (e.g., one with a high negative predictive value) 
such as D-dimer be performed in the setting of low or intermediate clinical prob-
ability of a PE [39]. In the cases where a PE is highly suspected or likely, it is pre-
ferred to proceed directly to imaging such as a computed tomography pulmonary 
arteriography (CTPA). The ease of obtaining it, combined with the high predictive 
value (92–96%), has placed CTPA as the dominant imaging modality for suspected 
PE [40]. In patients unable to receive iodinated contrast, a ventilation-perfusion 
(V-Q ) scan or a contrast-enhanced magnetic resonance angiography (MRA) may 
represent a valid alternative. MRA has a sensitivity of 78% and specificity of 99%. 
This imaging study, however, relies on patient participation and compliance, and 
therefore a nontrivial proportion of studies will be inadequate to obtain sufficient 
level of diagnostic accuracy [40]. Once diagnosed, the treatment of PE involves 
systemic anticoagulation, with more invasive measures such as thrombolysis or 
embolectomy performed in patients with significant hemodynamic instability, 
respiratory decompensation, or acute right ventricular dysfunction [37].
2.2 Fat emboli
Fat embolism syndrome (FES) differs in that there is no reliably accurate diagnos-
tic or imaging test. Rather, the diagnosis is primarily clinical [11]. Multiple scoring 
systems exist which utilize the findings of petechiae, respiratory symptoms, fever, 
tachycardia, and radiographic changes with these either being identified as “major” 
or “minor” in magnitude or assigned a value on a pre-determined scale [11, 21, 41]. 
The lack of an imaging confirmatory test, however, makes it difficult to evaluate the 
true diagnostic accuracy or sensitivity of these indices. Ultrasound and echocar-
diography have been used to detect circulating fat globules; however, several studies 
suggest that a much higher percentage of patients with long bone fractures have 
circulating fat globules than previously thought, and only a fraction of these patients 
develop symptoms or FES [21, 42]. Computed tomography (CT) and magnetic reso-
nance imaging (MRI) have been used, often with few abnormal findings reported. 
Treatment is mainly supportive and consists of intravenous fluids, respiratory sup-
port, and other forms of symptomatic management as appropriate. Medications such 
as steroids, heparin, alcohol, and dextran have not been proven beneficial [21].
2.3 Amniotic fluid embolism
Amniotic fluid embolism (AFE) is another condition that requires a high degree 
of clinical suspicion, as the diagnosis is based on a heterogeneous constellation 
of symptoms [9, 10]. AFE should be suspected in any case of sudden maternal 
cardiovascular collapse with accompanying coagulopathy, hypotension, seizures, 
or distress, with no other clearly identifiable cause [43–45]. There are currently no 
truly reliable laboratory tests that are diagnostic of AFE [46]. Detection of formed 
amniotic fluid components (epidermal squamous cells, meconium, or lanugo hairs) 
in the maternal pulmonary blood flow is sufficient for histologic diagnosis of AFE 
[20]. Unfortunately, in many cases AFE goes unrecognized until these findings are 
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Embolism type 
(alphabetical)
Risk factors
Air emboli [12, 16, 17, 48] • Venous catheterization, removal, manipulation, unintended 
disconnection
• CABG on CP bypass
• Craniotomy, especially in sitting position
• Fistulization between air filled viscus and vessel (aortoesophageal, 
atriobronchial)
• Traumatic or iatrogenic pulmonary alveoli-venous fistula
• PFO, VSD (for paradoxical air emboli)
• Hemodialysis, cell saver transfusion
Amniotic fluid [19, 20] • Multi-fetal pregnancy, placenta previa, placental abruption, eclampsia
• Uterine rupture
• Cell saver blood transfusion
• Induction, C-section, fetal distress, cervical laceration/trauma, instru-
ment delivery
• Maternal age > 35 years
Fat emboli [24, 49, 50] • Long bone fracture (pelvis, femur)
• Joint arthroplasty
• Percutaneous vertebroplasty
• Liposuction, fat grafting
• CABG
• CPR
• Organ transplant (lung, renal)
• Bone marrow transplant or harvest
• Chronic corticosteroid use
• Severe burn
Iatrogenic foreign body [14] • Guidewire–placement of central line, improper technique, or failure to 
control guidewire during procedure (more likely in emergency situa-
tions, inexperienced staff, inadequate supervision)
• Catheter–fracture of catheter secondary to repetitive mechanical stress, 
damage during removal, and improper connection during placement
• Coils–improperly sized or placed coils; tortuous vessels; usage of 
angioplasty balloon for deployment
Peripheral emboli [28–30] • PFO in setting of venous thrombosis
• Atrial fibrillation
• History of central or peripheral atherosclerosis
Pulmonary embolism  
(PE) [51]
• Trauma
• Prolonged hospitalization/immobility
• Malignancy
• Central venous catheterization, venous thrombosis, thrombophilia
CABG = Coronary artery bypass grafting; CP = Cardiopulmonary; CPR = Cardiopulmonary resuscitation; PFO = 
Patent foramen ovale; VSD = Ventricular septal defect.
Table 2. 
Listing of the most common risk factors by embolism type.
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seen on autopsy [9, 10]. Treatment is supportive, involving respiratory support, 
Cesarean section (if not already delivered), correction of coagulopathy, blood/
blood product transfusion, vasopressors/inotropes, and fluids [9, 10, 43–45].
2.4 Air embolism
The most sensitive test for diagnosing an air embolism is the transesophageal 
echo (TEE), detecting as little as 0.02 ml/kg of air administered by bolus injection 
[12, 37]. In fact, it has been deemed almost “too sensitive,” in that it will detect air 
in circulation that is not associated with any symptoms. A precordial Doppler is also 
highly sensitive, detecting as little as 0.25 ml of air (0.05 ml/kg) [37]. It is highly 
operator dependent, however, as one must rely on the detection of a change in 
sound with air interrupting the blood flow within the cardiac chambers. Much less 
sensitive is the pulmonary artery catheter, with a detection threshold of 0.25 mL/
kg of air [47]. Additionally, it is of limited use therapeutically as its small caliber 
internal lumen is often insufficient to withdraw air from the chamber as a thera-
peutic maneuver (or at least quickly enough to be truly effective). In the operating 
room, the most practical diagnostic tool is a sudden fall in end-tidal CO2, albeit this 
is highly nonspecific. Other times, air emboli will go undiagnosed by any formal 
means and may well end up being “presumed” based on clinical symptomatology 
presenting in a scenario where an air embolus is possible (Table 2).
2.5 Foreign body embolism
The method of detecting a foreign body embolus (FBE) is dependent on the 
resting intravascular location of the embolus, which may vary according to the 
etiology, object type, and route of introduction [13, 14, 52, 53]. For cardiac emboli, 
transesophageal echocardiography (TEE) is commonly used and is beneficial in that 
it can also assess for any structural damage associated with such FBEs [54]. This 
imaging modality may be limited, however, especially in instances when the emboli 
are small, minimally echogenic, located in difficult-to-access locations, or obscured 
by acoustic shadowing. In these cases, computed tomography (CT) imaging may 
represent a helpful adjunct to determine location and operative or endovascular 
plan for removal. CT angiography is also useful for more peripherally located FBEs 
[52, 53]. The decision on whether to remove the foreign body is also highly depen-
dent on symptomatology and potential complications of the emboli, especially 
when considered in the context of any downstream anatomic structures as well as 
immediately surrounding tissues. In the current age, an endovascular approach is 
the most common, with open approaches often reserved for failure of endovascular 
retrieval. Rarely, an embolus may be left in place if it is unlikely to further migrate 
and the patient is asymptomatic, though this does leave the patient at potential risk 
for future complications that can occur remotely, even years later [13, 14, 55, 56].
3. Conclusion
Perhaps the most valuable take-away message of this book is that diagnostic 
relativity—rather than absolutism—continues to prevail in the realm of “embolic 
diseases.” Such is the state of modern medical decision-making in this important 
area of active clinical investigation and management. Table 2 summarizes the most 
common risk factors, organized by “embolism” type. Compiled from variety of 
sources, this information represents an good foundation for clinical discussions 
based on diagnostic probabilities.
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In summary, this book represents a collection of contributions by a multidisci-
plinary team of clinicians and medical researchers. The editors’ goal was to solicit the 
highest quality contributions from some of the top experts in their respective fields. 
We hope we were able to achieve this goal satisfactorily. Ultimately, the book’s read-
ers will be the best arbiters of its success, whether it is determined by the number 
of downloaded chapters or the cumulative number of citations attributable to this 
collection of chapters. To be able to contribute to the generation and dissemination 
of new knowledge in this important area of clinical investigation is a true privilege.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
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